Literature DB >> 4160651

Methylprednisolone in the treatment of exophthalmos.

M I Garber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 4160651     DOI： 10.1016/s0140-6736(66)90954-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Pharmacological treatments for thyroid eye disease.

Authors:  Sara P Modjtahedi; Bobeck S Modjtahedi; Ahmad M Mansury; Dinesh Selva; Raymond S Douglas; Robert A Goldberg; Igal Leibovitch
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 2.  Immunosuppressant therapy of thyroid eye disease.

Authors:  G Kahaly; J Beyer
Journal:  Klin Wochenschr       Date:  1988-11-01

3.  Heterogeneity of failure of visual acuity in Graves' disease.

Authors:  Y Sachdev; J C Chatterji; R C Sharma
Journal:  Postgrad Med J       Date:  1979       Impact factor: 2.401

4.  Corticosteroids in the treatment of optic nerve involvement associated with thyroid dysfunction.

Authors:  R M Day; F D Carroll
Journal:  Trans Am Ophthalmol Soc       Date:  1967

5.  The assessment and treatment of endocrine exophthalmos.

Authors:  J S Cant
Journal:  Proc R Soc Med       Date:  1970-08

Review 6.  Thyroid eye disease: towards an evidence base for treatment in the 21st century.

Authors:  Erin F Gillespie; Terry J Smith; Raymond S Douglas
Journal:  Curr Neurol Neurosci Rep       Date:  2012-06       Impact factor: 5.081

7.  Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone.

Authors:  R Ebner; M H Devoto; D Weil; M Bordaberry; C Mir; H Martinez; L Bonelli; H Niepomniszcze
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

Review 8.  Graves' ophthalmopathy.

Authors:  J R Wall; J Henderson; C R Strakosch; D M Joyner
Journal:  Can Med Assoc J       Date:  1981-04-01       Impact factor: 8.262
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.